Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Q1 Trading Update

24 Sep 2025 07:01

RNS Number : 4899A
Time Finance PLC
24 September 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

24 September 2025

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Q1 Trading Update

 

Record Quarterly Revenues, Record Net Tangible Assets and Record Lending Book

 

Time Finance plc, the AIM listed independent specialist finance provider is pleased to provide the following update on the Group's trading performance for the first quarter of the current financial year covering the three months to 31 August 2025. The results reflect the continued strong demand for the Group's multi-product funding offering which has resulted in further growth across all key financial metrics. The lending book has now enjoyed seventeen consecutive quarters of growth, while the Group's continued lending discipline has delivered unchanged levels of arrears and write-offs.

 

Unaudited Q1 2025/26 financial highlights:

· Own-Book Lending Origination up 30% to £28.5m (Q1 2024/25: £22.0m)

· Revenue up 3% to £9.4m (Q1 2024/25: £9.1m)

· Profit before Tax up 11% to £2.1m (Q1 2024/25: £1.9m)

· Profit Before Tax margin up 100 bps to 22% (Q1 2024/25: 21%)

· Net Tangible Assets up 14% to £45.6m at 31 August 2025 (31 August 2024: £40.1m)

· Gross Lending Book up 8% to £221.1m at 31 August 2025 (31 August 2024: £205.3m)

· Net Arrears unchanged at 5% of the gross lending book at 31 August 2025 (31 August 2024: 5%)

· Net Bad Debt Write-Offs unchanged at 1% of the average gross lending book at 31 August 2025 (31 August 2024: 1%)

 

As targeted in the Company's three-year strategic plan through to May 2028 that was launched in January 2025, the Group's focus on secured lending through its Invoice Finance division and the 'Hard' subset of the wider Asset division has continued. These two product sets now account for approximately 85% of the entire lending book, up from 76% twelve months earlier. They have also accounted for over 95% of all new deals written in the first quarter of this financial year.

 

Ed Rimmer, Chief Executive Officer commented:

"As we enter the first year of our new three-year medium-term strategic plan, I am very encouraged that the initial quarter has continued to deliver increased growth in our lending book; a strengthened Balance Sheet with increased Net Tangible Assets; and record quarterly Revenues and Profit Before Tax. The lending book has now seen consistent increases for seventeen consecutive quarters, reflecting the demand for our multi-product offering and the value that is placed on our first-class customer service by UK businesses seeking access to finance. Net arrears and Net Bad Debt write-offs also continue to be well within our target ranges and underline our commitment to responsible and sustainable lending. The Board, therefore, retains confidence that the Group is positioned for further growth and will build increased value for its shareholders over time."

 

Outlook

The Board confirms that it continues to expect the Group's trading for the current financial year ending 31 May 2026 to be at least in line with market expectations.

 

 

Notice of Investor Presentation

As previously announced, the Company will deliver a live presentation relating to this trading update and the simultaneously released FY 2024/25 audited annual results announcement via the Group's investor website at 1pm BST today. The presentation is open to all existing and potential shareholders who can sign up via: https://investors.timefinance.com/webinars/oPB5mr-fy-results-2024-2025-webinar.

 

For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://investors.timefinance.com/s/71ba43. Here you will find all company news and additional content to further explain Time Finance's strategy and developments.

 

Ends

 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Joe Walker

Timefinance@walbrookpr.com

 

 

 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEMFEDEISEIU
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.